MedEA - Medical Education Academy

今天我們將與上海交通大學醫學院附屬瑞金醫院高血壓科主任、上海市高血壓研究所所長王繼光先生進行對話。

在本期播客結束時，聽眾應了解β受體阻斷劑作為心血管疾病一線治療藥物的作用，熟悉射血分數降低型心臟衰竭（HFrEF）治療的四大指南指導藥物治療支柱，並認識到早期應用指南指導的藥物治療對HFrEF治療至關重要。

本集播客是「從高血壓到心血管疾病2026：依從性、人工智慧與更年期」繼續醫學教育計畫的一部分，該計畫面向包括心臟病專家、內科醫生、全科醫生、執業護理師以及其他診斷和管理心血管疾病和高血壓患者的醫療保健專業人員。

Today we will be speaking with Jiguang Wang, Director of the Shanghai Institute of Hypertension, Director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine in Shanghai, China.

Сегодня с нами беседует Цзигуан Ван, директор Шанхайского института гипертензии, директор отделения гипертензии в больнице Жуйцзинь при медицинском факультете Шанхайского университета Цзяотун в Китае.

今天我們將訪問香港中文大學醫學院醫學及藥物治療學教授、香港糖尿病及肥胖症研究所所長陳麗娜教授。

在本播客結束時，學習者應該能夠理解心腎保護在第 2 型糖尿病過早死亡/發病中的重要性，並認識到多支柱管理方法對於改善心腎患者的預後至關重要。

本播客是「糖尿病前期、中間高血糖和 2 型糖尿病管理：2026 年監測和多系統健康指南」繼續醫學教育計畫的一部分，面向管理 2 型糖尿病患者的醫療保健專業人員，包括參與內分泌學的臨床醫生，特別是糖尿病、糖尿病前期、中間高血糖、肥胖管理和全科醫療的臨床醫生。

部分內容可能對血管專科醫生和心臟科醫生也有參考價值。

Today we will be speaking with Juliana Chan, Professor of Medicine and Therapeutics Director, Hong Kong Institute of Diabetes and Obesity, Faculty of Medicine, at the Chinese University of Hong Kong.

At the end of this podcast, learners should be able to understand the significance of cardiorenal protection in premature mortality/morbidity in type 2 diabetes and recognize that a multi-pillar management approach is essential to improve cardiorenal patient outcomes.

This podcast is part of the Continuing Medical Education program “Managing Prediabetes, Intermediate Hyperglycaemia and Type 2 Diabetes: 2026 guidelines on Monitoring and Multisystem Health”, targeting healthcare professionals managing patients with type 2 diabetes, including clinicians involved in endocrinology, particularly diabetes, prediabetes, intermediate hyperglycaemia, obesity management and general practice.

Some content may be of interest also to vascular specialists and cardiologists.

Hoy hablaremos con Juliana Chan, profesora de Medicina y Terapéutica, directora fundadora y directora del Hong Kong Institute of Diabetes and Obesity y de la Clinical Research Management Office de la Universidad China de Hong Kong.

Al finalizar este pódcast, los oyentes deberán ser capaces de comprender la importancia de la protección cardiorrenal para reducir la mortalidad y la morbilidad prematuras en la diabetes de tipo 2, así como reconocer que es esencial adoptar un enfoque terapéutico centrado en varios pilares para mejorar los resultados cardiorrenales de los pacientes.

Este pódcast forma parte del programa de formación médica continuada «Tratamiento de la prediabetes, la hiperglucemia intermedia y la diabetes de tipo 2: directrices de 2026 sobre seguimiento y salud multisistémica», dirigido a profesionales sanitarios que atienden a pacientes con diabetes de tipo 2, incluidos médicos especializados en endocrinología, en particular en diabetes, prediabetes, hiperglucemia intermedia, tratamiento de la obesidad y atención primaria.

Today we will be speaking with Lina Badimon from the Hospital Santa Creu and San Pau, Autonomous University of Barcelona in Spain.

Сегодня мы поговорим с Линой Бадимон из больницы Санта-Креу и Сан-Пау Автономного университета Барселоны в Испании.

今天，我们将对话来自西班牙巴塞罗那自治大学圣十字圣保罗医院的 Lina Badimon。

Today we will be speaking with Tadej Battelino, Consultant and Head of Department of Paediatric and Adolescent Endocrinology, UMC Ljubljana, as well as Head Chair of Paediatrics and Professor of Paediatrics at Faculty of Medicine, University of Ljubljana, Slovenia.

At the end of this podcast, learners should be able to understand that continuous glucose monitoring (CGM) can improve the rate and timing of dysglycemia detection and be aware that CGM real-time data may allow individualised interventions to help prevent disease progression.

This podcast is part of the Continuing Medical Education programme, ‘Managing Prediabetes, Intermediate Hyperglycemia and Type 2 Diabetes 2026.’ Guidelines on monitoring and multi-system health targeting healthcare professionals managing patients with type 2 diabetes, including clinicians involved in endocrinology, particularly diabetes, prediabetes, intermediate hyperglycemia, obesity management and general practice. Some content may be of interest also to vascular specialists and cardiologists.